Evidence map›Paper›PMID 37355639›Full record

ArticleAddiction science & clinical practice2023

"I wouldn't need Narcan for myself, but I can have it for somebody else:" perceptions of harm reduction among hospitalized patients with OUD.

Rachel French, M Holliday Davis, Shoshana V Aronowitz, Molly Crowe, Matthew Abrams, Grace Edwards, Margaret Lowenstein

Open access · goldAbstract read
In one paragraph

Article in Addiction science & clinical practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Rachel FrenchNational Clinician Scholars Program, University of Pennsylvania, 13th Floor Blockley Hall, 423 Guardian Drive, Philadelphia, PA, 19104, USA. Rachel.french@pennmedicine.upenn.edu.ORCID 0000-0003-0379-2974
M Holliday DavisPerelman School of Medicine, University of Pennsylvania, 423 Guardian Drive, Philadelphia, PA, 19104, USA.
Shoshana V AronowitzLeonard Davis Institute for Health Economics, University of Pennsylvania, 3641 Locust Walk, Philadelphia, PA, 19104, USA.
Molly CrowePerelman School of Medicine, University of Pennsylvania, 423 Guardian Drive, Philadelphia, PA, 19104, USA.
Matthew AbramsPerelman School of Medicine, University of Pennsylvania, 423 Guardian Drive, Philadelphia, PA, 19104, USA.
Grace EdwardsCollege of Arts and Sciences, University of Pennsylvania, 249 S 36th St, Philadelphia, PA, 19104, USA.
Margaret LowensteinLeonard Davis Institute for Health Economics, University of Pennsylvania, 3641 Locust Walk, Philadelphia, PA, 19104, USA.
University of Pennsylvania · USUniversity City Science Center · USUniversity of the Sciences · US

Funding

Improving transitions of care for hospitalized patients with opioid use disorderK23DA055087 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI Margaret Lowenstein · 2022 to 2026
$959k
Improving Opioid Use Disorder Treatment for Hospitalized Patients with EndocarditisF32DA053763 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI FRENCH, RACHEL ELIZABETH · 2021 to 2023
$210k
NIDA NIH HHS F32-DA053763NIDA NIH HHS K23 DA055087NIDA NIH HHS K23DA055087
6 · The paper itself

Abstract

backgroundExtant literature is limited on adoption of evidence-based harm reduction strategies in hospitals. We explored patient perceptions of incorporating harm reduction supplies and education in hospital care with patients with opioid use disorder (OUD).

methodsQualitative descriptive study of hospitalized patients with OUD in Philadelphia, PA using semi-structured interviews conducted between April and August of 2022.

resultsThree major themes emerged from 21 interviews with hospitalized patients with OUD: (1) Applicability and Acceptability of Harm Reduction Practices for Oneself; (2) Applicability and Acceptability of Harm Reduction Practices for Others; (3) Perceptions of Harm Reduction Conversations. Most participants were familiar with harm reduction but varied in their perceptions of its relevance for their lives. We noted differences in how participants viewed the applicability and acceptably of harm reduction practices that they perceived as intended to help others (e.g., naloxone) versus intended to help themselves (e.g., syringes). Most participants reported that meaningful conversations about drug use did not happen with their care team but that these conversations would have been acceptable if they were conducted in a way consistent with their individual substance use goals.

conclusionsPatients' interest and perceived acceptability of harm reduction services during hospitalization varied by individual patient factors and the perceived user of specific interventions. Given their positive potential, harm reduction practices should be incorporated in hospitals, but this must be done in a way that is acceptable to patients. Our findings reveal ways to integrate concepts from a harm reduction approach within a traditional medical model. More work is needed to understand the impact of such integration.

Indexed as

NaloxoneOpioid-Related DisordersHarm ReductionHospitalizationHumansQualitative ResearchNaloxoneAddictionFentanyl test stripsHarm reductionHospitalizationNaloxoneOpioid use disorderPatient-centered carePeople who use drugsSubstance use disorderSyringe service programs

Identifiers

PMID37355639
PMCPMC10290347
OpenAlexW4381929566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.